SCHEMBL6991241

SCHEMBL6991241

Cc1ccc(C#N)c2c(OCCNC(=O)OC(C)(C)C)noc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 5/20 0.40
CA1 P00915 5/20 0.40
CA2 P00918 5/20 0.40
CA9 Q16790 5/20 0.40
NSD2 O96028 1/20 0.39
KCNH2 Q12809 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
HPGD P15428 1/20 0.37
CYP2C19 P33261 1/20 0.37
AAK1 Q2M2I8 3/20 0.36
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
GABRA5 P31644 1/20 0.36
IDO1 P14902 1/20 0.35
PDK2 Q15119 1/20 0.35
SCN9A Q15858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6990613 0.89 CA12 (0.46) CA12CA1CA2CA9CYP2D6
SCHEMBL6992683 0.84 CA12 (0.40) CA12CA1CA2CA9NSD2
SCHEMBL6992143 0.83 CA12 (0.42) CA12CA1CA2CA9CYP2D6
SCHEMBL6988079 0.82 CA12 (0.41) CA12CA1CA2CA9KCNH2
SCHEMBL6990629 0.82 CA12 (0.43) CA12CA1CA2CA9CYP3A4
SCHEMBL6987703 0.82 CA12 (0.40) CA12CA1CA2CA9NSD2
SCHEMBL6993444 0.81 CA12 (0.43) CA12CA1CA2CA9HPGD
SCHEMBL6988571 0.79 CA12 (0.43) CA12CA1CA2CA9IDO1
SCHEMBL6987117 0.79 KCNH2 (0.39) CA12CA1CA2CA9NSD2
SCHEMBL6992284 0.78 CA12 (0.44) CA12CA1CA2CA9CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0779281-B1 ISOXAZOLES SANKYO CO (JP) 2003-10-29 EP disclosed
US-6096771-A ISOXAZOLE DERIVATIVES EXHIBITING EXCELLENT TYPE B AND TYPE A MONOAMINE OXIDASE INHIBITORY ACTIVITIES, THEREFORE USEFUL FOR PREVENTING PARKINSON'S DISEASE, DEPRESSION AND ALZHEIMER'S DISEASE SANKYO COMPANY, LIMITED (JP) 2000-08-01 US disclosed
US-5965591-A MONOAMINE OXIDASE INHIBITOR; FOR PROPHYLAXIS AND TREATING PARKINSON'S DISEASE, DEPRESSION AND ALZHEIMER'S DISEASE SANKYO COMPANY, LIMITED (JP) 1999-10-12 US disclosed
EP-0779281-A1 ISOXAZOLES SANKYO COMPANY LIMITED (JP) 1997-06-18 EP disclosed